IOT Innovotech Inc.

0.0454USD0.0650 CAD · TSXV-7.14%Mkt Cap: 2.47M USDP/E: —

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for…

Key Statistics

Company
Market Cap2.47M USD
Enterprise Value2.67M USD
Revenue (TTM)2.18M USD
Gross Profit1.68M USD
Net Income (TTM)65.97K USD
Revenue/Share0.04 USD
Last Price0.0454 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.46
EV/Revenue1.23
P/S1.14
P/B1.63
EPS (TTM)-0.01 USD
EPS (Forward)—
52W Range
0.04192% of range0.2027
52W High0.2027 USD
52W Low0.0419 USD
Profitability
Gross Margin52.86%
Oper. Margin-41.72%
EBITDA Margin-35.41%
Profit Margin2.08%
ROE2.62%
ROA2.13%
ROIC1.08%
ROCE0.61%
Growth
Revenue Growth-47.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-43.59K USD
CapEx (TTM)329.61K USD
FCF Margin-36.00%
FCF Yield-31.69%
Net Debt163.53K USD
Net Debt/EBITDA-0.21
Net Debt/FCF—
Balance Sheet
Debt/Equity0.04
Current Ratio2.28
Quick Ratio1.55
Book Value/Sh0.03 USD
Cash/Share0.0028 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.44M
Float30.59M
Insiders41.94%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short701
Short (prev mo.)701
Technical
SMA 500.0503 (-9.7%)
SMA 2000.0907 (-49.9%)
Beta1.38
S&P 52W Chg12.00%
Avg Vol (30d)41.46K
Avg Vol (10d)82.92K
Technical Indicators
RSI (14)45.7
MACD-0.0004
MACD Signal-0.0008
MACD Hist.+0.0004
BB Upper0.0581 USD
BB Middle0.0484 USD
BB Lower0.0387 USD
BB Width40.06%
ATR (14)0.0039 USD
Vol Ratio (20d)0.34x

About Innovotech (CVE: IOT)

›

Innovotech (CVE: IOT) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.0650 CAD on 19 November 2026, down 67.5% over 52 weeks. Its 52-week range is 0.0600 CAD to 0.2900 CAD: the price is 77.6% below the high and 8.3% above the low.

Its market capitalisation is 3.54M CAD.

Innovotech reports return on equity of 2.6%, an operating margin of -41.7% and revenue down 47.8% year over year.

Its debt exceeds its cash by 233.94K CAD, a debt-to-equity ratio of 0.04. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 30 March 2027.